德國Epigenomics AG
德國分子診斷公司Epigenomics 。Epigenomics公司致力于使用它的甲基化作用技術來開發領先的分子診斷產品和解決方案,以改善癌癥和其他常見疾病的診斷水平。
We are a molecular diagnostics company developing and commercializing a pipeline of proprietary products for the screening and diagnosis of cancer.
Our products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients.
Our lead product, Epi proColon, is a blood-based test for the early detection of colorectal cancer, which is currently marketed in Europe and is in development for the USA.
Our technology and products have been validated through multiple partnerships with leading global diagnostic companies including Abbott, QIAGEN, Sysmex and Quest Diagnostics.
We are an international company with operations in Europe and the USA.
?